Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bicycle Therapeutics plc - American Depositary Shares
(NQ:
BCYC
)
3.860
-0.080 (-2.03%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
352,219
Open
3.930
Bid (Size)
3.850 (900)
Ask (Size)
4.080 (100)
Prev. Close
3.940
Today's Range
3.850 - 4.030
52wk Range
3.850 - 9.159
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
May 21, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
April 30, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Performance
YTD
-42.2%
-42.2%
1 Month
-7.0%
-7.0%
3 Month
-18.4%
-18.4%
6 Month
-41.3%
-41.3%
1 Year
-54.7%
-54.7%
More News
Read More
Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting
April 21, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026
April 20, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026
March 18, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
March 17, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline
February 03, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026
January 12, 2026
From
Bicycle Therapeutics plc
Via
Business Wire
The Great Migration: Why International Tech and Biotech Giants are Redomiciling to the Massachusetts Hub
December 23, 2025
Via
MarketMinute
Topics
Economy
Initial Public Offering
Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline
December 16, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference
November 12, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
October 30, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Strengthens Board of Directors with New Appointments
September 08, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
4 Analysts Assess Bicycle Therapeutics: What You Need To Know
↗
August 12, 2025
Via
Benzinga
Bicycle (BCYC) Q2 Revenue Falls 69%
↗
August 08, 2025
Via
The Motley Fool
Topics
Intellectual Property
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
August 08, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews
↗
July 17, 2025
Via
Benzinga
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 03, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting
May 22, 2025
From
Bicycle Therapeutics
Via
Business Wire
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 05, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
A Glimpse Into The Expert Outlook On Bicycle Therapeutics Through 7 Analysts
↗
May 02, 2025
Via
Benzinga
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
May 01, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025
April 29, 2025
From
Bicycle Therapeutics plc
Via
Business Wire
Analyst Expectations For Bicycle Therapeutics's Future
↗
April 09, 2025
Via
Benzinga
Frequently Asked Questions
Is Bicycle Therapeutics plc - American Depositary Shares publicly traded?
Yes, Bicycle Therapeutics plc - American Depositary Shares is publicly traded.
What exchange does Bicycle Therapeutics plc - American Depositary Shares trade on?
Bicycle Therapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Bicycle Therapeutics plc - American Depositary Shares?
The ticker symbol for Bicycle Therapeutics plc - American Depositary Shares is BCYC on the Nasdaq Stock Market
What is the current price of Bicycle Therapeutics plc - American Depositary Shares?
The current price of Bicycle Therapeutics plc - American Depositary Shares is 3.860
When was Bicycle Therapeutics plc - American Depositary Shares last traded?
The last trade of Bicycle Therapeutics plc - American Depositary Shares was at 07/29/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
